Since nonmyeloablative host conditioning regimens are associated with reduced regimen-
related toxicities, advanced age and most comorbid medical conditions are no longer …

Hyperlipidemia is common after renal transplantation, and drugs that inhibit the 3-hydroxy-3-
methylglutaryl-coenzyme A reductase enzyme (statins) are frequently prescribed for these …

OBJECTIVE: To describe a case of rhabdomyolysis in a cadaveric renal transplant (CRT)
patient receiving atorvastatin and cyclosporine. CASE SUMMARY: A 40-year-old Asian …

Hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors are cholesterol-
lowering agents which may induce rhabdomyolysis. The authors present a case of …

Rhabdomyolysis, a syndrome characterized by muscle necrosis with release of toxic
intracellular muscle constituents, can be a potentially fatal side effect of medical therapy …

Background The 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors lovastatin
and simvastatin have been associated with rhabdomyolysis in cardiac transplant recipients …

In their recent report, Cohen et al (1) reported two cases of rhabdomyolysis in lung
transplant patients, and cyclosporin drug-interaction-induced rhabdomyolysis was …

Background: Cardiovascular disease is the most common cause of morbidity and mortality
among long-term renal transplant recipients, and hyperlipidemia is an important risk factor …

Background. Statins are widely used to decrease cholesterol and improve morbidity and
mortality associated with coronary artery disease. Myopathy constitutes a rare but potentially …

We describe two patients treated with a combination of cyclosporin and simvastatin who had
to be hospitalized due to rhabdomyolysis. As suggested by reduced cyclosporin clearance …